Contact us! Delta@CopyThat.us

Rogaine Men's Hair Loss & Hair Regrowth Treatment Minoxidil Foam, 4 Month Supply

$64.80

Rogaine Men's Hair Loss & Hair Regrowth Treatment Minoxidil Foam, 4 Month Supply

  • No mess 5% minoxidil foam with TRICHO-PRIME Technology, 4 month supply
  • Clinically proven to regrow up to 25% more hair(1) 
  • No topical treatment works faster to regrow fuller hair than ROGAINE
  • Use at early stages of thinning to help slow hair loss and maintain hair density for fuller, younger-looking hair
  • #1 Dermatologist Recommended Brand(2)
  • Satisfaction Guaranteed(3)

(1) Blume-Peytavi et al., 2016 (ClinicalTrials.gov identifier NCT01145625).

(2) Bergfeld et al., 2016 (ClinicalTrials.gov identifier NCT01226459).

(3) After 120 days of daily use.

OR
  • DESCRIPTION
  • REVIEWS
  • ManufacturerRogaine
    UPC312547781343
    ConditionNew

    Rogaine Men's Hair Loss & Hair Regrowth Treatment Minoxidil Foam, 4 Month Supply

    Product Description

    ROGAINE Men's Hair Loss & Hair Regrowth Treatment Minoxidil Foam, Four Month Supply

    As everyone ages, hair follicles begin to shrink, leading to thinning hair (or loss of hair density). Unlike hair loss shampoos or hair thickening products that temporarily plump hair from the outside, Rogaine 5% Minoxidil Foam with Tricho-prime Technology penetrates into the scalp to reactivate shrunken hair follicles, allowing for new fuller, younger-looking hair to regrow.

    Regrow Thicker, Fuller Hair

    Rogaine is clinically proven to regrow up to 25% more hair(1). No topical treatment works faster to grow fuller hair than Rogaine.

    At a Glance:

    • No mess 5% minoxidil foam with TRICHO-PRIME Technology, 4 month supply
    • Clinically proven to regrow up to 25% more hair(1) 
    • No topical treatment works faster to regrow fuller hair than ROGAINE
    • Use at early stages of thinning to help slow hair loss and maintain hair density for fuller, younger-looking hair
    • #1 Dermatologist Recommended Brand(2)
    • Satisfaction Guaranteed(3)

    (1) Blume-Peytavi et al., 2016 (ClinicalTrials.gov identifier NCT01145625).

    (2) Bergfeld et al., 2016 (ClinicalTrials.gov identifier NCT01226459).

    (3) After 120 days of daily use.